Invention Grant
- Patent Title: 2-oxonaphthyridine-3-carboxamides HIV integrase inhibitors
- Patent Title (中): 2-氧代萘啶-3-甲酰胺HIV整合酶抑制剂
-
Application No.: US10597902Application Date: 2005-02-10
-
Publication No.: US08691991B2Publication Date: 2014-04-08
- Inventor: Brian Alvin Johns , Eric Eugene Boros , Takshi Kawasuji , Cecilia S. Koble , Noriyuki Kurose , Hitoshi Murai , Ronald George Sherrill , Jason Gordon Weatherhead
- Applicant: Brian Alvin Johns , Eric Eugene Boros , Takshi Kawasuji , Cecilia S. Koble , Noriyuki Kurose , Hitoshi Murai , Ronald George Sherrill , Jason Gordon Weatherhead
- Applicant Address: JP Osaka US NC Research Triangle Park
- Assignee: Shionogi & Co., Ltd.,ViiV Healthcare Company
- Current Assignee: Shionogi & Co., Ltd.,ViiV Healthcare Company
- Current Assignee Address: JP Osaka US NC Research Triangle Park
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- International Application: PCT/US2005/004085 WO 20050210
- International Announcement: WO2005/077050 WO 20050825
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/4375
Abstract:
The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
Public/Granted literature
- US20070124152A1 Hiv Integrase Inhibitors Public/Granted day:2007-05-31
Information query
